276 related articles for article (PubMed ID: 9537257)
1. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.
Duncan LM; Deeds J; Hunter J; Shao J; Holmgren LM; Woolf EA; Tepper RI; Shyjan AW
Cancer Res; 1998 Apr; 58(7):1515-20. PubMed ID: 9537257
[TBL] [Abstract][Full Text] [Related]
2. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
3. Expression and Up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells.
Fang D; Setaluri V
Biochem Biophys Res Commun; 2000 Dec; 279(1):53-61. PubMed ID: 11112417
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal localization and genomic characterization of the mouse melastatin gene (Mlsn1).
Hunter JJ; Shao J; Smutko JS; Dussault BJ; Nagle DL; Woolf EA; Holmgren LM; Moore KJ; Shyjan AW
Genomics; 1998 Nov; 54(1):116-23. PubMed ID: 9806836
[TBL] [Abstract][Full Text] [Related]
5. CTp11, a novel member of the family of human cancer/testis antigens.
Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of cathepsin B expression in B16 melanomas of varying metastatic potential.
Qian F; Chan SJ; Achkar C; Steiner DF; Frankfater A
Biochem Biophys Res Commun; 1994 Jul; 202(1):429-36. PubMed ID: 8037744
[TBL] [Abstract][Full Text] [Related]
7. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
[TBL] [Abstract][Full Text] [Related]
8. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display.
van Groningen JJ; Bloemers HP; Swart GW
Cancer Res; 1995 Dec; 55(24):6237-43. PubMed ID: 8521420
[TBL] [Abstract][Full Text] [Related]
9. Expression of the transmembrane glycoprotein CD44 and metastasis associated 18A2/MTS1 gene in B16 murine melanoma cells.
Lakshmi MS; Parker C; Sherbet GV
Anticancer Res; 1997; 17(5A):3451-5. PubMed ID: 9413186
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
[TBL] [Abstract][Full Text] [Related]
11. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a novel Sry-related gene that is expressed in high-metastatic K-1735 murine melanoma cells.
Tani M; Shindo-Okada N; Hashimoto Y; Shiroishi T; Takenoshita S; Nagamachi Y; Yokota J
Genomics; 1997 Jan; 39(1):30-7. PubMed ID: 9027483
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of a single tropomyosin isoform, TM5/TM30nm, results in reduction in motility of highly metastatic B16-F10 mouse melanoma cells.
Miyado K; Kimura M; Taniguchi S
Biochem Biophys Res Commun; 1996 Aug; 225(2):427-35. PubMed ID: 8753779
[TBL] [Abstract][Full Text] [Related]
15. Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line.
Brem R; Hildebrandt T; Jarsch M; Van Muijen GN; Weidle UH
Anticancer Res; 2001; 21(3B):1731-40. PubMed ID: 11497253
[TBL] [Abstract][Full Text] [Related]
16. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
17. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
Yamit-Hezi A; Plaksin D; Eisenbach L
Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
[TBL] [Abstract][Full Text] [Related]
18. [Immunogenicity of 2 murine B16 melanoma variants with high metastatic potential].
Hosni M; Santini R; Deschaux P; Pacheco H
C R Seances Soc Biol Fil; 1990; 184(1):47-54. PubMed ID: 2150781
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
